1	Temperature-induced	temperature-induced	_	_	_	_	_	_	_
2	down-regulation	down-regulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
6	receptor	receptor	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	peripheral	peripheral	_	_	_	_	_	_	_
9	blood	blood	_	_	_	_	_	_	_
10	mononuclear	mononuclear	_	_	_	_	_	_	_
11	leucocyte	leucocyte	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	patients	patient	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	sepsis	sepsis	_	_	_	_	_	_	_
16	or	or	_	_	_	_	_	_	_
17	septic	septic	_	_	_	_	_	_	_
18	shock	shock	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	OBJECTIVE	objective	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Activation	Activation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	_	_	_	_	_	_	_
7	axis	axis	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	vital	vital	_	_	_	_	_	_	_
11	importance	importance	_	_	_	_	_	_	_
12	during	during	_	_	_	_	_	_	_
13	critical	critical	_	_	_	_	_	_	_
14	illness	illness	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	have	have	_	_	_	_	_	_	_
3	studied	study	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	adaptive	adaptive	_	_	_	_	_	_	_
6	mechanisms	mechanism	_	_	_	_	_	_	_
7	which	which	_	_	_	_	_	_	_
8	occur	occur	_	_	_	_	_	_	_
9	at	at	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	level	level	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
18	target	target	_	_	_	_	_	_	_
19	tissues	tissue	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	patients	patient	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	sepsis	sepsis	_	_	_	_	_	_	_
24	or	or	_	_	_	_	_	_	_
25	septic	septic	_	_	_	_	_	_	_
26	shock	shock	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	DESIGN	design	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	The	the	_	_	_	_	_	_	_
4	effects	effect	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	hypercortisolaemia	hypercortisolaemia	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	hyperthermia	hyperthermia	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	cellular	cellular	_	_	_	_	_	_	_
11	composition	composition	_	_	_	_	_	_	_
12	on	on	_	_	_	_	_	_	_
13	number	number	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
16	receptors	receptor	_	_	_	_	_	_	_
17	per	per	_	_	_	_	_	_	_
18	cell	cell	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	their	their	_	_	_	_	_	_	_
21	affinity	affinity	_	_	_	_	_	_	_
22	were	be	_	_	_	_	_	_	_
23	evaluated	evaluate	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	both	both	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	vitro	vitro	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	vivo	vivo	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	peripheral	peripheral	_	_	_	_	_	_	_
34	blood	blood	_	_	_	_	_	_	_
35	mononuclear	mononuclear	_	_	_	_	_	_	_
36	leucocytes	leucocyte	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	control	control	_	_	_	_	_	_	_
39	subjects	subject	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	patients	patient	_	_	_	_	_	_	_
43	with	with	_	_	_	_	_	_	_
44	sepsis	sepsis	_	_	_	_	_	_	_
45	or	or	_	_	_	_	_	_	_
46	septic	septic	_	_	_	_	_	_	_
47	shock	shock	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

1	SUBJECTS	subjects	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Fifteen	fifteen	_	_	_	_	_	_	_
4	patients	patient	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	age	age	_	_	_	_	_	_	_
7	25-79	25-79	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	sepsis	sepsis	_	_	_	_	_	_	_
11	or	or	_	_	_	_	_	_	_
12	septic	septic	_	_	_	_	_	_	_
13	shock	shock	_	_	_	_	_	_	_
14	who	who	_	_	_	_	_	_	_
15	were	be	_	_	_	_	_	_	_
16	admitted	admit	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	intensive	intensive	_	_	_	_	_	_	_
20	care	care	_	_	_	_	_	_	_
21	unit	unit	_	_	_	_	_	_	_
22	were	be	_	_	_	_	_	_	_
23	studied	study	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	control	control	_	_	_	_	_	_	_
3	group	group	_	_	_	_	_	_	_
4	consisted	consist	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	24	24	_	_	_	_	_	_	_
7	healthy	healthy	_	_	_	_	_	_	_
8	laboratory	laboratory	_	_	_	_	_	_	_
9	employees	employee	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	MEASUREMENTS	measurements	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	The	the	_	_	_	_	_	_	_
4	binding	binding	_	_	_	_	_	_	_
5	capacity	capacity	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	affinity	affinity	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
11	receptors	receptor	_	_	_	_	_	_	_
12	were	be	_	_	_	_	_	_	_
13	measured	measure	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	compared	compare	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	clinical	clinical	_	_	_	_	_	_	_
18	data	datum	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	plasma	plasma	_	_	_	_	_	_	_
22	cortisol	cortisol	_	_	_	_	_	_	_
23	concentrations	concentration	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Hypercortisolaemia	Hypercortisolaemia	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	vitro	vitro	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	resulted	result	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	decreased	decrease	_	_	_	_	_	_	_
12	affinity	affinity	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	decreased	decrease	_	_	_	_	_	_	_
16	binding	binding	_	_	_	_	_	_	_
17	capacity	capacity	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
21	receptor	receptor	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	vitro	vitro	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	hyperthermia	hyperthermia	_	_	_	_	_	_	_
5	as	as	_	_	_	_	_	_	_
6	well	well	_	_	_	_	_	_	_
7	as	as	_	_	_	_	_	_	_
8	variations	variation	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	cellular	cellular	_	_	_	_	_	_	_
12	composition	composition	_	_	_	_	_	_	_
13	did	do	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	influence	influence	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
18	receptor	receptor	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	vivo	vivo	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	there	there	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	no	no	_	_	_	_	_	_	_
7	change	change	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	number	number	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	receptors	receptor	_	_	_	_	_	_	_
13	per	per	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	patients	patient	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	sepsis	sepsis	_	_	_	_	_	_	_
19	or	or	_	_	_	_	_	_	_
20	septic	septic	_	_	_	_	_	_	_
21	shock	shock	_	_	_	_	_	_	_
22	as	as	_	_	_	_	_	_	_
23	compared	compare	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	healthy	healthy	_	_	_	_	_	_	_
26	controls	control	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	decreased	decrease	_	_	_	_	_	_	_
5	affinity	affinity	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
9	receptor	receptor	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	observed	observe	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	There	there	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	weak	weak	_	_	_	_	_	_	_
5	but	but	_	_	_	_	_	_	_
6	significant	significant	_	_	_	_	_	_	_
7	negative	negative	_	_	_	_	_	_	_
8	correlation	correlation	_	_	_	_	_	_	_
9	between	between	_	_	_	_	_	_	_
10	body	body	_	_	_	_	_	_	_
11	temperature	temperature	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	number	number	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
17	receptors	receptor	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	patient	patient	_	_	_	_	_	_	_
21	group	group	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	There	there	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	no	no	_	_	_	_	_	_	_
4	relation	relation	_	_	_	_	_	_	_
5	between	between	_	_	_	_	_	_	_
6	circulating	circulate	_	_	_	_	_	_	_
7	cortisol	cortisol	_	_	_	_	_	_	_
8	concentrations	concentration	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
11	receptor	receptor	_	_	_	_	_	_	_
12	affinity	affinity	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	number	number	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	CONCLUSIONS	conclusions	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	There	there	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	no	no	_	_	_	_	_	_	_
6	obvious	obvious	_	_	_	_	_	_	_
7	regulation	regulation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	number	number	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
13	receptors	receptor	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	plasma	plasma	_	_	_	_	_	_	_
16	cortisol	cortisol	_	_	_	_	_	_	_
17	concentrations	concentration	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	vivo	vivo	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	decreased	decrease	_	_	_	_	_	_	_
3	affinity	affinity	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
7	receptor	receptor	_	_	_	_	_	_	_
8	together	together	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	negative	negative	_	_	_	_	_	_	_
12	correlation	correlation	_	_	_	_	_	_	_
13	between	between	_	_	_	_	_	_	_
14	hyperthermia	hyperthermia	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	number	number	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
20	receptors	receptor	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	patients	patient	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	sepsis	sepsis	_	_	_	_	_	_	_
25	or	or	_	_	_	_	_	_	_
26	septic	septic	_	_	_	_	_	_	_
27	shock	shock	_	_	_	_	_	_	_
28	suggest	suggest	_	_	_	_	_	_	_
29	that	that	_	_	_	_	_	_	_
30	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	_	_	_	_	_	_	_
31	axis	axis	_	_	_	_	_	_	_
32	activation	activation	_	_	_	_	_	_	_
33	during	during	_	_	_	_	_	_	_
34	critical	critical	_	_	_	_	_	_	_
35	illness	illness	_	_	_	_	_	_	_
36	is	be	_	_	_	_	_	_	_
37	accompanied	accompany	_	_	_	_	_	_	_
38	by	by	_	_	_	_	_	_	_
39	peripheral	peripheral	_	_	_	_	_	_	_
40	adaptation	adaptation	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
43	receptor	receptor	_	_	_	_	_	_	_
44	number	number	_	_	_	_	_	_	_
45	and	and	_	_	_	_	_	_	_
46	affinity	affinity	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

